Can a steroid help seniors regain muscle? new trial investigates
NCT ID NCT05978206
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a drug called nandrolone decanoate, combined with a structured exercise and diet program, can improve strength and mobility in older adults with sarcopenia (age-related muscle loss). About 168 people aged 60–99 will receive either the drug or a placebo, plus the same exercise and diet plan, for 12 weeks. Researchers will measure changes in walking speed, chair-stand time, and overall physical function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
nandrolone decanoate (an anabolic steroid)
What this could lead to
If it works, this could point toward a treatment for sarcopenia that combines medication, exercise, and diet to help older adults regain strength and mobility.
What could go wrong
This is an early Phase 2 trial with only 168 people, so results may not apply to everyone. The steroid may cause side effects like hormonal changes or liver issues, and the benefit over exercise and diet alone is uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centrum Wsparcia Badań Klinicznych
RECRUITINGWarsaw, Masovian Voivodeship, 02-637, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••